Cargando…
E3 Ligase FBXW2 Is a New Therapeutic Target in Obesity and Atherosclerosis
Chronic low‐grade inflammation orchestrated by macrophages plays a critical role in metabolic chronic diseases, like obesity and atherosclerosis. However, the underlying mechanism remains to be elucidated. Here, the E3 ubiquitin ligase F‐box/WD Repeat‐Containing Protein 2 (FBXW2), the substrate‐bind...
Autores principales: | Wang, Cheng, Xu, Wenjing, Chao, Yuelin, Liang, Minglu, Zhang, Fengxiao, Huang, Kai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578860/ https://www.ncbi.nlm.nih.gov/pubmed/33101872 http://dx.doi.org/10.1002/advs.202001800 |
Ejemplares similares
-
FBXW7 E3 ubiquitin ligase: degrading, not degrading, or being degraded
por: Lan, Huiyin, et al.
Publicado: (2019) -
E3 Ligase FBXW7 Facilitates Mycobacterium Immune Evasion by Modulating TNF-α Expression
por: Song, Jingrui, et al.
Publicado: (2022) -
E3 ligase FBXW7 is critical for RIG-I stabilization during antiviral responses
por: Song, Yinjing, et al.
Publicado: (2017) -
Absence of Interferon Regulatory Factor 1 Protects Against Atherosclerosis in Apolipoprotein E-Deficient Mice
por: Du, Meng, et al.
Publicado: (2019) -
E3 ligase FBXW7 restricts M2-like tumor-associated macrophage polarization by targeting c-Myc
por: Zhong, Lijia, et al.
Publicado: (2020)